Sophia Genetics Sa earnings were -$62.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SOPH earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$15.2M, down 17.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SOPH reported annual earnings of -$62.5M, with -20.9% growth. The next SOPH earnings date is May 5, 2025.
What were Sophia Genetics Sa's earnings last quarter?
On SOPH's earnings call on Invalid Date, Sophia Genetics Sa (NASDAQ: SOPH) reported Q4 2024 earnings per share (EPS) of -$0.23, up 37.84% year over year. Total SOPH earnings for the quarter were -$15.16 million. In the same quarter last year, Sophia Genetics Sa's earnings per share (EPS) was -$0.37.
The next SOPH earnings date is Invalid Date. Add SOPH to your watchlist to be reminded of Sophia Genetics Sa's next earnings date.
What was SOPH's earnings growth in the past year?
As of Sophia Genetics Sa's earnings date in Invalid Date, Sophia Genetics Sa's earnings has grown year over year. SOPH earnings in the past year totalled -$62.49 million.
Is Sophia Genetics Sa profitable or losing money?
As of the last Sophia Genetics Sa earnings report, Sophia Genetics Sa is currently losing money. Sophia Genetics Sa's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$62.49 million, a 20.88% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.